bell
The current prices are delayed by 15 mins, login to check live prices.
Wanbury Ltd share price logo

Wanbury Ltd

(WANBURY)

₹241.310.86%

as on 06:59PM, 01 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Wanbury Ltd Performance

  • Day's Low

    Day's High

    ₹236.5
    ₹247.4
  • 52 Week's Low

    52 Week's High

    ₹87.9
    ₹290.2
1 Month Return-4.32 %
3 Month Return+ 12.27 %
1 Year Return+ 161.87 %
Previous Close₹239.25
Open₹240.00
Volume69.26K
Upper Circuit-
Lower Circuit-
Market Cap₹783.79Cr

Wanbury Ltd Key Statistics

P/E Ratio15.09
PEG Ratio0.97
Market Cap₹783.79 Cr
P/B Ratio21.77
EPS17.09
Dividend Yield0
SectorPharmaceuticals
ROE38.26

Wanbury Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹783.79 Cr370.79%0.91₹55 Cr₹575 Cr
NA₹136.73 Cr9.85%0.59NANA
NA₹2,410.53 Cr173.57%0.62₹43 Cr₹381 Cr
NA₹162.20 Cr101.48%0.58NANA
NA₹18,538.81 Cr70.96%0.77-₹472 Cr₹2,798 Cr

About Wanbury Ltd

Wanbury Ltd Formerly known Pearl Organics Limited was incorporated in August 1988. The Company is engaged in the business of pharmaceutical and related activities including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995 the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996 it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 200708 the merger of Doctors Organic Chemicals Limited DOCL with the Company became effective from 1st April 2007. Pursuant to the aforesaid Order of the Honble Bl FR 785557 Equity Shares of face value of Rs. 10/ each of the Company were issued to the Equity Shareholders of DOCL on 17th March 2008. Similarly the Pharmaceutical Products of India Limited PPIL was merged with the Company effective from April 1 2006. In terms of the said Scheme of Merger the Company had issued 562618 Equity Shares of face value of Rs. 10/ each to the Equity Shareholders of PPIL on 27 June 2007 which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in ZurichSwitzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product Cdense Gems was launched in May 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched MyotolF targeted at female infertility in 2013 it launched Folinine. The Companys newly launched products MyotolF to treat polycystic ovarian syndrome and CalK2 in prevention and management of Osteoporosis were labelled as one of the best launches in 2014..

Share Price: ₹241.31 per share as on 01 Nov, 2024 06:59 PM
Market Capitalisation: ₹783.79Cr as of today
Revenue: ₹131.11Cr as on June 2024 (Q2 24)
Net Profit: ₹1.04Cr as on June 2024 (Q2 24)
Listing date: 29 Jan, 2007
Chairperson Name: K Chandran
OrganisationWanbury Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Wanbury Ltd

  • Wanbury Shares Surge on New API Launch Announcements - 12 Sep, 2024

    Wanbury Ltd's shares hit a 5% upper circuit after announcing the launch of two new APIs, Dextromethorphan and Ketamine, alongside a robust pipeline of products. Despite a decline in quarterly profits, the stock has appreciated significantly year-to-date.

  • Wanbury Secures CEP for Cough Relief Drug - 09 Sep, 2024

    Wanbury Ltd. has received a Certificate of Suitability for its cough suppressant Dextromethorphan, allowing sales in Europe. The company faces challenges with declining profits and revenues due to facility upgrades.

  • Wanbury Shares Rise After USFDA Inspection Success - 23 Aug, 2024

    Wanbury Ltd's shares surged after receiving an Establishment Inspection Report from the USFDA with zero observations, indicating compliance with good manufacturing practices. The company also received awards for safety performance.

  • Wanbury Reports Decline in Sales and Profit - 17 Aug, 2024

    Wanbury's June 2024 net sales fell 10.38% to Rs 131.11 crore, with net profit down 77.87% to Rs 1.04 crore. Despite this, shares have gained 11.87% over six months and 237.21% over the past year.

Insights on Wanbury Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, WANBURY stock has moved up by 161.9%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.22% to 1.02% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 165.89 Cr → 132.05 Cr (in ₹), with an average decrease of 20.4% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 59.98% to 59.20% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 33.63 Cr → 1.04 Cr (in ₹), with an average decrease of 96.9% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 39.79% to 39.77% in Sep 2024 quarter

Wanbury Ltd Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹146.29Cr (-)₹144.46Cr (↓1.25%)₹145.50Cr (↑0.72%)₹139.41Cr (↓4.19%)₹131.11Cr (↓5.95%)
Net Income₹4.69Cr (-)₹7.36Cr (↑56.93%)₹10.27Cr (↑39.54%)₹33.63Cr (↑227.46%)₹1.04Cr (↓96.91%)
Net Profit Margin3.21% (-)5.09% (↑58.57%)7.06% (↑38.70%)24.12% (↑241.64%)0.79% (↓96.72%)
Value in ₹ crore
Details2021202220232024
Total Assets₹287.60Cr (-)₹351.00Cr (↑22.04%)₹301.88Cr (↓13.99%)₹343.49Cr (↑13.78%)
Total Liabilities₹418.25Cr (-)₹348.81Cr (↓16.60%)₹309.13Cr (↓11.38%)₹315.54Cr (↑2.07%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹44.13Cr (-)₹16.68Cr (↓62.20%)₹40.52Cr (↑142.93%)₹19.80Cr (↓51.14%)₹4.02Cr (↓79.70%)
0

Wanbury Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
39.77%
-0.05
Foreign Institutions
1.02%
356.34
Mutual Funds
0%
0.00
Retail Investors
59.2%
-1.30
Others
0%
6.25

Wanbury Ltd Key Indicators

Details20202021202220232024
Return On Assets %23.26-4.3823.21-3.4516.29
Details20202021202220232024
Book Value Per Share (₹)-57.39-62.46-7.27-10.076.7
Details20202021202220232024
Earning Per Share (₹)25.79-5.0424.94-3.1817.09
Details202020222024
Return On Equity %48.9637.0338.26

Wanbury Ltd Valuation

Wanbury Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-105.12x)

July 15, 2021

Today (15.09x)

November 1, 2024

Industry (57.19x)

November 1, 2024

Highest (146.91x)

September 29, 2023

LowHigh

Wanbury Ltd Earnings and Dividends

  • Wanbury Ltd Earnings Results

    Wanbury Ltd’s net profit fell -77.83% since last year same period to ₹1.04Cr in the Q1 2024-2025. On a quarterly growth basis, Wanbury Ltd has generated -96.91% fall in its net profits since last 3-months.

    Read More about Earnings Results

Wanbury Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Wanbury Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Wanbury Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Wanbury Ltd shares.

Wanbury Ltd (WANBURY) share price today is ₹241.31

Wanbury Ltd is listed on NSE

Wanbury Ltd is listed on BSE

  • Today’s highest price of Wanbury Ltd is ₹247.4.
  • Today’s lowest price of Wanbury Ltd is ₹236.5.

PE Ratio of Wanbury Ltd is 15.09

PE ratio = Wanbury Ltd Market price per share / Wanbury Ltd Earnings per share

Today’s traded volume of Wanbury Ltd(WANBURY) is 69.26K.

Today’s market capitalisation of Wanbury Ltd(WANBURY) is ₹783.79Cr.

Wanbury Ltd(WANBURYPrice
52 Week High
₹290.2
52 Week Low
₹87.9

Wanbury Ltd(WANBURY) share price is ₹241.31. It is down -16.85% from its 52 Week High price of ₹290.2

Wanbury Ltd(WANBURY) share price is ₹241.31. It is up 174.53% from its 52 Week Low price of ₹87.9

Wanbury Ltd(WANBURYReturns
1 Day Returns
2.06%
1 Month Returns
-4.32%
3 Month Returns
12.27%
1 Year Returns
161.87%